286 filings
Page 3 of 15
8-K
1nxou4b7zntp n2
9 May 22
FibroGen Reports First Quarter 2022 Financial Results
4:09pm
UPLOAD
il0 wgneape
3 May 22
Letter from SEC
12:00am
DEFA14A
67j0 n1obsjz
28 Apr 22
Additional proxy soliciting materials
7:11pm
8-K
3m73p wryxm4tw
28 Feb 22
FibroGen Reports Fourth Quarter and Full Year 2021 Financial Results
4:06pm
CORRESP
eg7f 8i7buumsa
11 Feb 22
Correspondence with SEC
12:00am
UPLOAD
i3j6dqfyrf
2 Feb 22
Letter from SEC
12:00am
CORRESP
kx7t9uxqqx6538ky
20 Jan 22
Correspondence with SEC
12:00am
UPLOAD
kv4c qtfhvgrrqlfxm
5 Jan 22
Letter from SEC
12:00am
CORRESP
12vf0atrn794re2
16 Dec 21
Correspondence with SEC
12:00am
8-K
wsatkmdxxxdfrhk
9 Nov 21
FibroGen Reports Third Quarter 2021 Financial Results
4:06pm
UPLOAD
opejp5
8 Nov 21
Letter from SEC
12:00am
8-K
0a9wjh
27 Aug 21
Departure of Directors or Certain Officers
4:31pm
8-K
0hsq j3pxbmg
20 Aug 21
Other Events
12:00am
8-K
k6vqvw4x
16 Aug 21
FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial Officer
5:23pm
8-K
8qjsqall4647q9wer4w
11 Aug 21
FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease
8:30am